Skip to main content

Philip Morris International Inc.

For the period ended Sep 30, 2026. Filed Oct 23, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Oct 23, 2026

PM$197.88-1.8%Stored close · as of Nov 6, 2026

What changed in Management’s Discussion and Analysis?

Read the current filing

Previous report: 10-Q

Period ended 2026-06-30; filed 2026-07-24.

0001628280-26-049493

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Current report: 10-Q

Period ended 2026-09-30; filed 2026-10-23.

0001628280-26-066976

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.

Compared 482 previous paragraphs and 490 current paragraphs.

333 unchanged; 116 reworded; 40 added; 23 removed; 10 previous and 1 current paragraphs rearranged.

Tables are not compared: 18 previous and 18 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.

A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.

Added paragraphs (40)

Current report

Consolidated Operating Results for the Nine Months Ended September 30, 2026

Current report

Dutch pension plan buy-out loss – In the third quarter of 2026, PMI recorded a pre-tax settlement loss of $74 million (representing $65 million net of income tax or $0.04 per share decrease in diluted EPS) related to the buy-out of our Dutch defined benefit pension plan through the transfer of the plan's pension obligations to a third-party insurer. For further details, see Note 4. Benefit Plans.

Current report

Germany excise tax classification litigation charge –In August 2024, the German Main Custom Office (“MCO”) notified Philip Morris (Germany) GmbH (“PM Germany”) of its decision to classify TEREA consumables as a cigarette for excise tax purposes with the associated tax assessment totaling EUR 151 million (approximately $176 million) covering the period of February 15, 2023, through August 1, 2024. In April 2025, PM Germany paid the outstanding amount, which was recorded in Other assets on the consolidated balance sheets, while it challenged the MCO’s decision in court. On September 17, 2025, PM Germany filed a request to withdraw the proceedings. As a result, the tax assessment amount of $176 million (representing $150 million net of income tax and a diluted EPS charge of $0.10 per share) was recorded as a pre-tax charge in marketing, administration and research costs in the condensed consolidated statements of earnings for the nine months ended September 30, 2025.

Current report

Impairment of Wellness business related equity investment – In the third quarter of 2025, PMI recorded a non-cash after tax charge of $146 million (representing a diluted EPS charge of $0.09 per share), primarily representing an other-than-temporary impairment of one equity method investment within the Wellness business following a reassessment of its estimated fair value triggered by the amendment of existing investment agreements in the third quarter of 2025. The impairment charge was recorded in equity investments and securities (income)/loss, net in the condensed consolidated statements of earnings for the nine months ended September 30, 2025.

Current report

RBH (Canada) Plan implementation, including dividend income, net – On August 29, 2025, the plan of compromise and arrangement (the “Plan”) setting forth the terms of a resolution of Canadian tobacco claims and related litigation became effective. In the third quarter of 2025, we recorded after-tax income of $156 million ($0.10 per share increase in diluted EPS) following the Plan implementation, including $303 million of dividend income net of the corresponding decrease in the carrying value of the RBH investment, $19 million of other income and the related income tax charge of $166 million. For further details, see Note 10. Income Taxesand Note 13. Related Parties - Equity Investments and Other.

Current report

•U.S. segment: Unfavorable volume/mix and higher manufacturing costs, partly offset by slightly favorable price comparisons against promotional activity in the third quarter last year; and

Current report

During the quarter, net revenues increased by 5.5%. Net revenues, excluding currency and acquisitions/divestitures, increased by 7.1%, mainly reflecting: a favorable pricing variance driven by international combustibles and the U.S. segment.

Current report

Germany excise tax classification litigation charge –In August 2024, the German Main Custom Office (“MCO”) notified Philip Morris (Germany) GmbH (“PM Germany”) of its decision to classify TEREA consumables as a cigarette for excise tax purposes with the associated tax assessment totaling EUR 151 million (approximately $176 million) covering the period of February 15, 2023, through August 1, 2024. In April 2025, PM Germany paid the outstanding amount, which was recorded in Other assets on the consolidated balance sheets, while it challenged the MCO’s decision in court. On September 17, 2025, PM Germany filed a request to withdraw the proceedings. As a result, the tax assessment amount of $176 million (representing $150 million net of income tax and a diluted EPS charge of $0.10 per share) was recorded as a pre-tax charge in marketing, administration and research costs in the condensed consolidated statements of earnings in the third quarter of 2025.

Current report

Impairment of Wellness business related equity investment – In the third quarter of 2025, PMI recorded a non-cash after tax charge of $146 million (representing a diluted EPS charge of $0.09 per share), primarily representing an other-than-temporary impairment of one equity method investment within the Wellness business following a reassessment of its estimated fair value triggered by the amendment of existing investment agreements in the third quarter of 2025. The impairment charge was recorded in equity investments and securities (income)/loss, net in the condensed consolidated statements of earnings in the third quarter of 2025.

Current report

RBH (Canada) Plan implementation, including dividend income, net – On August 29, 2025, the plan of compromise and arrangement (the “Plan”) setting forth the terms of a resolution of Canadian tobacco claims and related litigation became effective. In the third quarter of 2025, we recorded after-tax income of $156 million ($0.10 per share increase in diluted EPS) following the Plan implementation, including $303 million of dividend income net of the corresponding decrease in the carrying value of the RBH investment, $19 million of other income and the related income tax charge of $166 million. For further details, see Note 10. Income Taxesand Note 13. Related Parties - Equity Investments and Other.

Current report

Dutch pension plan buy-out loss – In the third quarter of 2026, PMI recorded a pre-tax settlement loss of $74 million (representing $65 million net of income tax or $0.04 per share decrease in diluted EPS) related to the buy-out of our Dutch defined benefit pension plan through the transfer of the plan's pension obligations to a third-party insurer. For further details, see Note 4. Benefit Plans.

Current report

The 2025 tax items that increased our 2025 diluted EPS by $0.14 per share in the table above were due to benefits related to an interest expense election primarily driven by a reduction related to 2024 tax costs associated with global intangible low-taxed income and refunds expected on amended tax returns filed in Germany; partially offset by valuation allowances recorded on deferred tax assets related to U.S. foreign tax credits. For further details, see Note 10. Income Taxes.

Current report

•International Combustibles segment: Favorable pricing and the restructuring of distribution terms in certain markets, partly offset by unfavorable volume/mix and increases in energy-related input prices;

Current report

•U.S. segment: Growing ZYN shipment volume and a favorable price variance against prior year promotions, partly offset by higher manufacturing costs; and

Current report

•Germany excise tax classification litigation charge – See discussion in the "Executive Summary" section of this MD&A for details of the pre-tax charge included in marketing, administration and research costs for the nine months and three months ended September 30, 2025.

Current report

Adjusted in-market sales or "adjusted IMS" is defined as in-market sales excluding distributor and/or trade inventory movements, which are estimated using a number of internal and external sources. Past reported periods may be updated to ensure comparability and to incorporate the most current information.

Current report

Consolidated Operating Results for the Nine Months Ended September 30, 2026

Current report

Gross profit increased by 9.4%. Gross profit, excluding currency and acquisitions/divestitures, increased by 7.1%, mainly reflecting the same factors as for net revenues, partly offset by higher manufacturing costs.

Current report

(1) Cost variance includes charges in 2025 of $176 million related to the Germany excise tax classification litigation. For more details, see the "Executive Summary" section of this MD&A.

Current report

During the quarter, net revenues increased by 5.5%. Net revenues, excluding currency and acquisitions/divestitures, increased by 7.1%, mainly reflecting: a favorable pricing variance driven by international combustibles and the U.S. segment.

Current report

Operating income increased by 14.1%. Operating income, excluding currency and acquisitions/divestitures, increased by 15.1%, largely reflecting the same factors as for gross profit and the 2025 Germany excise tax classification litigation charge of $176 million.

Current report

Gross profit increased by 0.8%. Gross profit, excluding currency and acquisitions/divestitures, increased by 3.3%, mainly due to the same factors as for net revenues.

Current report

Gross profit increased by 14.3%. Gross profit, excluding currency and acquisitions/divestitures, increased by 11.8%, mainly due to the same factors as for net revenues, supported by favorable manufacturing efficiencies.

Current report

•In Japan, PMI HTU adjusted IMS grew by 3.4%, or by 1.3% excluding the estimated consumer pantry-loading impact ahead of the October 1 excise-driven price increase (JPY20 per pack). This continues to be broadly in line with our expectations as consumers adjust following the first excise-driven price increase (JPY40 per pack) on April 1. IQOS maintained a strong category share at 68%, with SENTIA continuing to play a key role in capturing price-sensitive TEREA consumers.

Current report

•In Europe, IQOS HTU adjusted IMS growth strengthened to an estimated 6.0%, notwithstanding ongoing disruptions in Ukraine and the continued impact of the characterizing flavor ban in Poland. IQOS HTU adjusted market share increased by 0.9 percentage points to 11.6%. This growth was led by strong performance in many markets, notably Germany, Greece, Spain and Romania. Adjusted IMS in Italy continued its strong growth trajectory, underscoring the category's significant potential across the region. Excluding Poland, adjusted IMS volumes grew by around 8%.

Current report

•Outside Europe and Japan, adjusted IMS grew by 12.7% and offtake share increased in key cities across the globe, including Riyadh, Kuala Lumpur, Mexico City, Jakarta and Taipei, underlining the global growth potential of the heat-not-burn category.

Current report

During the quarter, net revenues increased by 6.5%. Net revenues, excluding currency and acquisitions/divestitures, increased by 7.8%, reflecting: a favorable pricing variance, and the favorable impact of the 2026 restructuring of prior distribution terms in certain markets, partially offset by unfavorable geographic mix.

Current report

Gross profit increased by 8.6%. Gross profit, excluding currency and acquisitions/divestitures, increased by 9.8% due to the same factors as for net revenues, slightly offset by higher costs due to increases in energy-related input prices.

Current report

For the nine months ended September 30, 2026, net revenues increased by 7.7%. Net revenues, excluding currency and acquisitions/divestitures, increased by 5.2%, reflecting: a favorable pricing variance and the previously mentioned favorable impact of the 2026 restructuring of prior distribution terms in certain markets, partially offset by unfavorable volume/mix.

Current report

Gross profit increased by 9.9%. Gross profit, excluding currency and acquisitions/divestitures, increased by 7.4%, due to the same factors as for net revenues, and slightly offset by increases in energy-related input prices.

Current report

During the quarter, net revenues increased by 22.7%. Net revenues, excluding currency and acquisitions/divestitures, also increased by 22.7%, primarily reflecting: growing ZYN shipments of 4.2%, and a favorable price variance against prior year promotions, supported by growth in the Wellness business and cigars.

Current report

In the third quarter, our U.S. smoke-free product shipment volume increased by 2.3%. Our U.S. oral smoke-free products shipment volume increased by 2.3% to 3.7 billion equivalent units, including a 4.2% increase in ZYN shipments to 3.2 billion pouches, despite challenging comparisons against a special promotional campaign last year and supported by the ongoing launches of ZYN ULTRA, new flagship dry flavors, and 1.5mg and 8mg flagship variants. These portfolio extensions enable ZYN to cover a broader range of consumer preferences and compete in the most dynamic growing segments of the category. We expect fourth quarter ZYN shipment volumes to be broadly in-line to modestly above third quarter levels, as we continue to expand distribution and support the rollout of the enhanced portfolio.

Current report

As part of our previously announced plans to accelerate investments in the second half, and with distribution of the extended range of ZYN products continuing to progress, we plan to further increase investments to support the brand in the fourth quarter. This reflects a ramp-up in consumer communications, notably an expansion of the 'When It Clicks' brand campaign, and the transition of the majority of the ZYN flagship portfolio to 20-pouch cans (from 15-pouch cans today), including associated transitional support programs. The change to 20-pouch cans is designed to align the value proposition across the portfolio and optimize ZYN's price premium to support future growth in the dynamic U.S. nicotine pouch category.

Current report

The transition to 20-pouch cans represents a significant investment in consumer value, which - all else equal - translates into approximately 25% less revenue-per-pouch. Combined with additional short-term support to manage the changeover at retail, this will impact fourth quarter net revenues. Taking the aggregate impact of these actions and the expansion of our manufacturing capacity to support future growth, the fourth quarter of 2026 will be a unique quarter of investment. We expect an abnormally low level of U.S. profitability in the fourth quarter.

Current report

The CoP and other WHO bodies have, from time to time, considered regulatory approaches to SFPs, including heated tobacco products, e-vapor products and nicotine pouches. These discussions and related policy recommendations may influence how jurisdictions regulate such products, including through restrictions on product availability, product characteristics, marketing and communication.

Current report

Some governments have sought, or may seek, to standardize the design and functionality of SFPs, or to set minimum quality and safety requirements for SFPs, including heat-not-burn products, e-Vapor products, and modern oral pouches. These regulatory requirements may be mandatory or voluntary, depending on the market and can create challenges with the commercialization of our SFPs. For example, Egypt, the Philippines, Japan, UK, and Mexico have adopted minimum quality and safety requirements for certain SFPs.

Current report

On December 16, 2021, PMTAs were submitted for ZYN ULTRA products, a newer line of nicotine pouches with modified pouch design, higher moisture content, in two nicotine strengths (9 mg and 11 mg). On August 21, 2026, the FDA authorized the marketing of 11 ZYN ULTRA nicotine pouch products, including all 9 mg variants and one 11 mg variant. The FDA’s evaluation found that the new products, including the 11 mg variant, contain lower levels of most HPHCs compared to other oral and smokeless tobacco products, with many constituents present at levels too low to be quantified. Additional 11 mg variants remain under scientific review.

Current report

The evolution of the situation in Ukraine has caused certain disruptions to our business this year, including the impact of strikes on our supply chain and logistics infrastructure in certain locations. We expect this disruption to have an impact on our operating income this year.

Current report

During the first nine months of 2026, net cash provided by operating activities was $10.4 billion as compared to $7.5 billion in the first nine months of 2025. Excluding favorable currency movements, the favorable variance of $2.8 billion was primarily due to lower working capital requirements of $1.9 billion and refunds of surplus assets from pension plans of $0.7 billion. For further details, see Note 4. Benefit Plans.

Current report

For the nine months ended September 30, 2026, our Russian operations accounted for around 7% of our total net revenues and our Ukrainian operations accounted for around 1% of our total net revenues.
Removed paragraphs (23)

Previous report

Consolidated Operating Results for the Six Months Ended June 30, 2026

Previous report

•U.S. segment: Unfavorable volume/mix, unfavorable pricing and higher manufacturing costs; and

Previous report

During the quarter, net revenues increased by 10.4%. Net revenues, excluding currency and acquisitions/divestitures, increased by 7.6%, mainly reflecting: a favorable pricing variance mainly driven by international combustibles; supported by favorable volume/mix, driven by international smoke-free volumes, notwithstanding adverse international combustibles mix.

Previous report

•U.S. segment: Unfavorable volume/mix, mostly driven by cigars, and higher manufacturing costs; and

Previous report

Consolidated Operating Results for the Six Months Ended June 30, 2026

Previous report

Gross profit increased by 10.9%. Gross profit, excluding currency and acquisitions/divestitures, increased by 6.4%, mainly reflecting the same factors as for net revenues, partly offset by higher manufacturing costs.

Previous report

During the quarter, net revenues increased by 10.4%. Net revenues, excluding currency and acquisitions/divestitures, increased by 7.6%, mainly reflecting: a favorable pricing variance mainly driven by international combustibles; supported by favorable volume/mix, driven by international smoke-free volumes, notwithstanding adverse international combustibles mix.

Previous report

Operating income increased by 22.0%. Operating income, excluding currency and acquisitions/divestitures, increased by 20.0%, mainly reflecting: a favorable pricing variance and lower restructuring charges in 2026, partly offset by unfavorable volume/mix.

Previous report

Gross profit increased by 17.1%. Gross profit, excluding currency and acquisitions/divestitures, increased by 14.6%, mainly due to the same factors as for net revenues.

Previous report

Gross profit increased by 22.6%. Gross profit, excluding currency and acquisitions/divestitures, increased by 16.9%, mainly due to the same factors as for net revenues.

Previous report

During the quarter, net revenues increased by 9.8%. Net revenues, excluding currency and acquisitions/divestitures, increased by 6.4%, reflecting: a favorable pricing variance, partially offset by unfavorable mix as growth in developing economies more than offset declines in Europe.

Previous report

Gross profit increased by 11.5%. Gross profit, excluding currency and acquisitions/divestitures, increased by 8.0%, due to the same factors as for net revenues.

Previous report

For the six months ended June 30, 2026, net revenues increased by 8.4%. Net revenues, excluding currency and acquisitions/divestitures, increased by 3.8%, reflecting: an unfavorable volume/mix; more than offset by a favorable pricing variance.

Previous report

Gross profit increased by 10.7%. Gross profit, excluding currency and acquisitions/divestitures, increased by 6.1%, due to the same factors as for net revenues.

Previous report

During the quarter, net revenues decreased by 0.7%. Net revenues, excluding currency and acquisitions/divestitures, decreased by 0.9%, primarily reflecting: broadly stable ZYN revenues, declines in the cigar business, and unfavorable phasing dynamics in Wellness.

Previous report

In the second quarter, our U.S. smoke-free product shipment volume increased by 1.8%. Our U.S. oral smoke-free products shipment volume increased by 1.8% to 3.5 billion equivalent units, including a 1.8% increase in ZYN shipments to 2.9 billion pouches, despite an inventory tailwind in the second quarter of 2025. ZYN offtake volumes were flat to slightly growing versus the prior year in a growing category, largely as a result of the uneven competitive landscape. In June, we expanded the ZYN portfolio with the first shipments of ZYN ULTRA (9mg and 11mg moist variants at a lower price-per-pouch), as well as additional flavors within the ZYN dry flagship lineup. To support the newly expanded ZYN portfolio, we intend to accelerate U.S. investments in the second half to maximize the long-term value of the brand and also prepare for the future launch of IQOS ILUMA.

Previous report

The WHO study group on tobacco product regulation published their ninth and tenth reports on the scientific basis of tobacco product regulation in August 2023 and November 2025, respectively. The reports are based on a review of scientific evidence related to novel and emerging nicotine and tobacco products, such as electronic nicotine delivery systems ("ENDS"), electronic non-nicotine delivery systems and HTPs. The report concludes by making a number of policy recommendations on HTPs and ENDS that, if implemented, could restrict both the availability of these products and access to accurate information about them.

Previous report

Currently, national standards in certain countries set minimum quality and safety requirements for heat-not-burn products with technical heat-not-burn specifications and/or methods for demonstrating the absence of combustion, including, for example, Egypt, Indonesia, Kazakhstan, Lebanon, Morocco, the Philippines, Russia, Saudi Arabia, the United Arab Emirates ("UAE"), the United Kingdom ("UK") and Ukraine. These standards may be mandatory or voluntary, depending on the market. In Japan, a voluntary standard sets minimum safety requirements for tobacco heating devices.

Previous report

For e-Vapor products, national standards setting minimum quality and safety requirements have been adopted in several markets, including, for example, Australia, China, Egypt, Indonesia, Morocco, the Philippines, Russia, Saudi Arabia, the UAE, the UK and Ukraine. These standards may be mandatory or voluntary, depending on the market.

Previous report

Currently, national standards setting minimum quality and safety requirements for modern oral pouches have been adopted by the East African Community, as well as in several countries, including, for example, Mexico, Morocco, Pakistan, the Philippines, Sweden, UAE, the UK, and Ukraine. These standards may be mandatory or voluntary, depending on the market.

Previous report

During the first six months of 2026, net cash provided by operating activities was $5.1 billion as compared to $3.1 billion in the first six months of 2025. Excluding favorable currency movements, the favorable variance of $1.9 billion was primarily due to lower working capital requirements of $1.5 billion, and higher currency-neutral net earnings, excluding non-cash depreciation and amortization expense, non-cash movements in deferred income tax benefit, the impairment charge related to the RBH equity investment and non-cash movements related to the changes in the fair value of our investments in equity securities reflected in Other (for further details, see Note 13. Related Parties – Equity Investments and Other).

Previous report

In 2025, Russia accounted for around 9% of our total cigarette and heated tobacco unit shipment volume, and around 6% of our total net revenues. Ukraine accounted for around 2% of our total cigarette and heated tobacco unit shipment volume, and around 1% of our total net revenues.
Reworded paragraphs (116)

Previous wording

We are a leading international consumer goods company, actively delivering a smoke-free future. We are evolving our portfolio for the long term to include products outside of the tobacco and nicotine sector. Our current product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, nicotine pouch and e-vapor products. Since 2008, we have invested over $16 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke or use other nicotine-containing consumer products, with the goal of completely ending the sale of cigarettes. This investment includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. In November 2022, we acquired Swedish Match AB ("Swedish Match") – a leader in oral nicotine delivery – creating a global smoke-free combination led by the companies’IQOS and ZYN brands. As of April 30, 2024, we hold the full rights to commercialize IQOS in the U.S. after reaching an agreement to end our U.S. commercial relationship covering IQOS with Altria Group, Inc. in 2022. Following a robust science-based review, the U.S. Food and Drug Administration (the "FDA") has authorized the marketing of Swedish Match’s General snus and ZYNnicotine pouches and versions of PMI’s IQOS devices and consumables - the first-ever such authorizations in their respective categories. Versions of IQOS devices and consumables, General snus and 20 ZYN nicotine pouch variants also obtained the first-ever Modified Risk Tobacco Product ("MRTP") authorizations from the FDA. We describe the MRTP orders in more detail in the "Business Environment" section of this Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A").

Current wording

We are a leading international consumer goods company, actively delivering a smoke-free future. We are evolving our portfolio for the long term to include products outside of the tobacco and nicotine sector. Our current product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, nicotine pouch and e-vapor products. Since 2008, we have invested over $16 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for legal-age adults who would otherwise smoke or use other nicotine-containing consumer products, with the goal of completely ending the sale of cigarettes. This investment includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. In November 2022, we acquired Swedish Match AB ("Swedish Match") – a leader in oral nicotine delivery – creating a global smoke-free combination led by the companies’IQOS and ZYN brands. As of April 30, 2024, we hold the full rights to commercialize IQOS in the U.S. after reaching an agreement to end our U.S. commercial relationship covering IQOS with Altria Group, Inc. in 2022. Following a robust science-based review, the U.S. Food and Drug Administration (the "FDA") has authorized the marketing of Swedish Match’s General snus and ZYNnicotine pouches and versions of PMI’s IQOS devices and consumables - the first-ever such authorizations in their respective categories. Versions of IQOS devices and consumables, General snus and 20 ZYN nicotine pouch variants also obtained the first-ever Modified Risk Tobacco Product ("MRTP") authorizations from the FDA. We describe the MRTP orders in more detail in the "Business Environment" section of this Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A").

Previous wording

IQOS, ZYN and VEEV are the leading brands in our SFPs portfolio. As of June 30, 2026, our smoke-free products were available for sale in 109 markets.

Current wording

IQOS, ZYN and VEEV are the leading brands in our SFPs portfolio. As of September 30, 2026, our smoke-free products were available for sale in 110 markets.

Previous wording

•Net Revenues - Net revenues of $21.3 billion for the six months ended June 30, 2026, increased by $1.9 billion, or 9.8%, from the comparable 2025 amount. The change in our net revenues from the comparable 2025 amount was driven by the following (variances not to scale with year-to-date results):

Current wording

•Net Revenues - Net revenues of $32.8 billion for the nine months ended September 30, 2026, increased by $2.5 billion, or 8.2%, from the comparable 2025 amount. The change in our net revenues from the comparable 2025 amount was driven by the following (variances not to scale with year-to-date results):

Previous wording

For the six months ended June 30, 2026, net revenues increased by 9.8%. Net revenues, excluding currency and acquisitions/divestitures, increased by 5.3%, mainly reflecting: a favorable pricing variance mainly driven by international combustibles; partly offset by unfavorable volume/mix, mainly driven by lower international combustibles and U.S. volumes, notwithstanding higher international smoke-free volumes.

Current wording

For the nine months ended September 30, 2026, net revenues increased by 8.2%. Net revenues, excluding currency and acquisitions/divestitures, increased by 5.9%, mainly reflecting: a favorable pricing variance mainly driven by international combustibles, and higher international smoke-free volumes; partly offset by unfavorable volume/mix, mainly driven by lower international combustibles and U.S. volumes in the first quarter.

Previous wording

Net revenues by product category for the six months ended June 30, 2026 and 2025 are shown below:

Current wording

Net revenues by product category for the nine months ended September 30, 2026 and 2025 are shown below:

Previous wording

•Diluted Earnings Per Share - The changes in our reported diluted earnings per share (“diluted EPS”) for the six months ended June 30, 2026, from the comparable 2025 amounts, were as follows:

Current wording

•Diluted Earnings Per Share - The changes in our reported diluted earnings per share (“diluted EPS”) for the nine months ended September 30, 2026, from the comparable 2025 amounts, were as follows:

Previous wording

Restructuring charges – During the six months ended June 30, 2025, we recorded pre-tax restructuring charges of $243 million (representing $200 million net of income tax and a diluted EPS charge of $0.13 per share), related to the end of combustible tobacco production in two of our factories in Germany. During the six months ended June 30, 2026, we recorded pre-tax restructuring charges of $30 million(representing $24 millionnet of income tax and a diluted EPS charge of$0.01 per share), related to a series of footprint optimization initiatives in the U.S. For further details, see Note 15. Restructuring Activities.

Current wording

Restructuring charges – During the nine months ended September 30, 2025, we recorded pre-tax restructuring charges of $243 million (representing $200 million net of income tax and a diluted EPS charge of $0.13 per share), related to the end of combustible tobacco production in two of our factories in Germany. During the nine months ended September 30, 2026, we recorded pre-tax restructuring charges of $34 million(representing $27 millionnet of income tax and a diluted EPS charge of$0.02 per share), related to a series of footprint optimization initiatives in the U.S. For further details, see Note 15. Restructuring Activities.

Previous wording

Amortization of intangibles –During the six months ended June 30, 2025 and 2026, we recorded amortization of intangibles expense of $496 million (representing $385 million net of income tax or $0.24 per share decrease in diluted EPS) and $503 million (representing$392 million net of income tax or $0.25 per share decrease in diluted EPS), respectively.

Current wording

Amortization of intangibles –During the nine months ended September 30, 2025 and 2026, we recorded amortization of intangibles expense of $746 million (representing $580 million net of income tax or $0.37 per share decrease in diluted EPS) and $750 million (representing$584 million net of income tax or $0.37 per share decrease in diluted EPS), respectively.

Previous wording

Fair value adjustment for equity security investments –During the six months ended June 30, 2025 and 2026, we recorded fair value adjustments for our equity security investments in India and Sri Lanka of $410 million gain after tax (or $0.26 per share increase in diluted EPS) and $240 million loss after tax (or $0.16 per share decrease in diluted EPS), respectively. For further details, see Note 13. Related Parties - Equity Investments and Other.

Current wording

Fair value adjustment for equity security investments –During the nine months ended September 30, 2025 and 2026, we recorded fair value adjustments for our equity security investments in India and Sri Lanka of $513 million gain after tax (or $0.33 per share increase in diluted EPS) and $339 million loss after tax (or $0.22 per share decrease in diluted EPS), respectively. For further details, see Note 13. Related Parties - Equity Investments and Other.

Previous wording

Impairment related to RBH equity investment –In May 2026, pursuant to its obligation under its court-approved plan of compromise and arrangement (the "Plan"), RBH provided an annual business plan to its Plan Administrator containing updated five-year financial projections reflecting current industry dynamics. As a result, PMI determined that the estimated fair value of its investment in RBH was lower than its carrying value and recorded a non-cash impairment charge of $511 million (representing $0.33 per share decrease in diluted EPS) in the second quarter of 2026. For further details, see Note 13. Related Parties - Equity Investments and Other.

Current wording

Impairment related to RBH equity investment –In May 2026, pursuant to its obligation under the Plan, RBH provided an annual business plan to its Plan Administrator containing updated five-year financial projections reflecting current industry dynamics. As a result, PMI determined that the estimated fair value of its investment in RBH was lower than its carrying value and recorded a non-cash impairment charge of $511 million (representing $0.33 per share decrease in diluted EPS) in the second quarter of 2026. For further details, see Note 13. Related Parties - Equity Investments and Other.

Previous wording

Income taxes – The income tax impact associated with the Swedish Match acquisition financing that increased our 2025 diluted EPS by $0.24 per share and decreased our 2026 diluted EPS by $0.06 per share in the table above was due to a deferred tax impact for unrealized foreign currency gains and losses on intercompany loans related to the Swedish Match acquisition financing reflected in the condensed consolidated statements of earnings, while the underlying pre-tax foreign currency movements fully offset in the condensed consolidated statements of earnings and were reflected as currency translation adjustments in the condensed consolidated statements of stockholders' (deficit) equity.

Current wording

Income taxes – The income tax impact associated with the Swedish Match acquisition financing that increased our 2025 diluted EPS by $0.24 per share and decreased our 2026 diluted EPS by $0.07 per share in the table above was due to a deferred tax impact for unrealized foreign currency gains and losses on intercompany loans related to the Swedish Match acquisition financing reflected in the condensed consolidated statements of earnings, while the underlying pre-tax foreign currency movements fully offset in the condensed consolidated statements of earnings and were reflected as currency translation adjustments in the condensed consolidated statements of stockholders' (deficit) equity.

Previous wording

The 2025 tax items that decreased our 2025 diluted EPS by $0.03 per share in the table above were due to the recognition of current tax expense related to the potential disallowance of deductions for certain intercompany transactions in Indonesia.

Current wording

The 2025 tax items that increased our 2025 diluted EPS by $0.11 per share in the table above were due to benefits related to an interest expense election primarily driven by a reduction in prior year tax costs associated with global intangible low-taxed income and refunds expected on amended tax returns filed in Germany; partially offset by valuation allowances recorded on deferred tax assets related to U.S. foreign tax credits and the recognition of current tax expense related to the potential disallowance of deductions for certain intercompany transactions in Indonesia.

Previous wording

The change in the tax rate that increased our diluted EPS by $0.11 per share in the table above was primarily driven by a reduction in tax costs associated with global intangible low-taxed income and discrete tax benefits recognized during the period. For further details, see Note 10. Income Taxes.

Current wording

The change in the tax rate that increased our diluted EPS by $0.03 per share in the table above was primarily driven by discrete tax benefits recognized during the period. For further details, see Note 10. Income Taxes.

Previous wording

Currency– The favorable impact of $0.22 per share from currency over the comparable 2025 period primarily results from the fluctuations of the U.S. dollar, especially against the Euro and Russian ruble, partly offset by the Japanese yen and Swiss franc. This favorable currency movement has impacted our profitability across our primary revenue markets and local currency cost bases.

Current wording

Currency– The favorable impact of $0.20 per share from currency over the comparable 2025 period primarily results from the fluctuations of the U.S. dollar, especially against the Euro and Russian ruble, partly offset by the Japanese yen. This favorable currency movement has impacted our profitability across our primary revenue markets and local currency cost bases.

Previous wording

Interest – The favorable impact of $0.02 per share from interest in the table above was primarily due to higher interest income on investments

Current wording

Interest – The favorable impact of $0.03 per share from interest in the table above was primarily due to higher interest income on investments.

Previous wording

Operations – The increase in diluted EPS of $0.21 from our operations in the table above was due primarily to the following:

Current wording

Operations – The increase in diluted EPS of $0.43 from our operations in the table above was due primarily to the following:

Previous wording

•International Smoke-Free segment: Favorable volume/mix and favorable pricing; and

Current wording

•International Smoke-Free segment: Favorable volume/mix, favorable pricing and lower manufacturing costs; and

Previous wording

•International Combustibles segment: Favorable pricing, partly offset by unfavorable volume/mix;

Current wording

•International Combustibles segment: Favorable pricing and the restructuring of distribution terms in certain markets, partly offset by unfavorable volume/mix and increases in energy-related input prices.

Previous wording

•Net Revenues - Net revenues of $11.2 billion for the three months ended June 30, 2026, increased by $1.1 billion, or 10.4%, from the comparable 2025 amount. The change in our net revenues from the comparable 2025 amount was driven by the following (variances not to scale with quarterly results):

Current wording

•Net Revenues - Net revenues of $11.4 billion for the three months ended September 30, 2026, increased by $0.6 billion, or 5.5%, from the comparable 2025 amount. The change in our net revenues from the comparable 2025 amount was driven by the following (variances not to scale with quarterly results):

Previous wording

Amortization of intangibles –During the second quarter of 2025 and 2026, we recorded amortization of intangibles expense of $250 million (representing $194 million net of income tax or $0.12 per share decrease in diluted EPS) and $252 million (representing $196 million net of income tax or $0.13 per share decrease in diluted EPS), respectively.

Current wording

Amortization of intangibles –During the third quarter of 2025 and 2026, we recorded amortization of intangibles expense of $250 million (representing $195 million net of income tax or $0.13 per share decrease in diluted EPS) and $247 million (representing $192 million net of income tax or $0.13 per share decrease in diluted EPS), respectively.

Previous wording

Fair value adjustment for equity security investments –During the second quarter of 2025 and 2026, we recorded fair value adjustments for our equity security investments in India and Sri Lanka of $267 million gain after tax (or $0.17 per share increase in diluted EPS) and $98 million gain after tax (or $0.06 per share increase in diluted EPS), respectively. For further details, see Note 13. Related Parties - Equity Investments and Other.

Current wording

Fair value adjustment for equity security investments –During the third quarter of 2025 and 2026, we recorded fair value adjustments for our equity security investments in India and Sri Lanka of $103 million gain after tax (or $0.07 per share increase in diluted EPS) and $99 million loss after tax (or $0.06 per share decrease in diluted EPS), respectively. For further details, see Note 13. Related Parties - Equity Investments and Other.

Previous wording

Income taxes – The income tax impact associated with the Swedish Match acquisition financing that increased our 2025 diluted EPS by $0.18 and decreased our 2026 diluted EPS by $0.01 in the table above was due to a deferred tax impact for unrealized foreign currency gains and losses on intercompany loans related to the Swedish Match acquisition financing reflected in the condensed consolidated statements of earnings, while the underlying pre-tax foreign currency movements fully offset in the condensed consolidated statements of earnings and were reflected as currency translation adjustments in the condensed consolidated statements of stockholders' (deficit) equity.

Current wording

Income taxes – The income tax impact associated with the Swedish Match acquisition financing that decreased our 2026 diluted EPS by $0.01 in the table above was due to a deferred tax impact for unrealized foreign currency gains and losses on intercompany loans related to the Swedish Match acquisition financing reflected in the condensed consolidated statements of earnings, while the underlying pre-tax foreign currency movements fully offset in the condensed consolidated statements of earnings and were reflected as currency translation adjustments in the condensed consolidated statements of stockholders' (deficit) equity.

Previous wording

The change in the tax rate that increased our diluted EPS by $0.05 per share in the table above was primarily driven by a reduction in tax costs associated with global intangible low-taxed income and discrete tax benefits recognized during the period.

Current wording

The change in the tax rate that decreased our diluted EPS by $0.08 per share in the table above was primarily driven by benefits related to an interest expense election primarily driven by a reduction in 2025 tax costs associated with global intangible low-taxed income.

Previous wording

Currency– The favorable impact of $0.03 per share from currency over the comparable 2025 period primarily results from the fluctuations of the U.S. dollar, especially against the Euro and the Russian ruble. This favorable currency movement has impacted our profitability across our primary revenue markets and local currency cost bases.

Current wording

Currency– The unfavorable impact of $0.01 per share from currency over the comparable 2025 period primarily results from the fluctuations of the U.S. dollar, especially against the Euro and Japanese yen, partly offset by the Russian ruble and Swiss franc. This unfavorable currency movement has impacted our profitability across our primary revenue markets and local currency cost bases.

Previous wording

See pages 77 -88 for a discussion of our "Cautionary Factors That May Affect Future Results." Net revenues, cost of sales and gross profit by segment, as well as total significant expenses and operating income were as follows:

Current wording

See pages 80 -91 for a discussion of our "Cautionary Factors That May Affect Future Results." Net revenues, cost of sales and gross profit by segment, as well as total significant expenses and operating income were as follows:

Previous wording

•Restructuring charges – See Note 15. Restructuring Activities for details of the pre-tax charges included in marketing, administration and research costs for the six months and three months ended June 30, 2026 and 2025.

Current wording

•Restructuring charges – See Note 15. Restructuring Activities for details of the pre-tax charges included in marketing, administration and research costs for the nine months and three months ended September 30, 2026 and 2025.

Previous wording

•Impairment of goodwill –See Note 5. Goodwill and Other Intangible Assets, net for details of the goodwill impairment charge recorded for the six months and three months ended June 30, 2025.

Current wording

•Impairment of goodwill –See Note 5. Goodwill and Other Intangible Assets, net for details of the goodwill impairment charge recorded for the nine months ended September 30, 2025.

Previous wording

The following discussion compares our consolidated operating results for the six months ended June 30, 2026, with the six months ended June 30, 2025.

Current wording

The following discussion compares our consolidated operating results for the nine months ended September 30, 2026, with the nine months ended September 30, 2025.

Previous wording

Our shipment volume, including cigarettes and smoke-free products (in equivalent units), increased by 0.4% with smoke-free volumes, up by 8.3%, driven by HTU and E-vapor categories, partly offset by cigarette volumes, down by 1.9%.

Current wording

Our shipment volume, including cigarettes and smoke-free products (in equivalent units), increased by 0.5% with smoke-free volumes, up by 6.4%, driven by HTU and E-vapor categories, partly offset by cigarette volumes, down by 1.2%.

Previous wording

For the full year 2026, we currently expect a broadly stable to slightly growing (previously broadly stable) total PMI cigarette and SFP shipment volume, with high-single digit SFP shipment volume growth, and a cigarette shipment volume decline of 2% to 3%, (previously around 3%).

Current wording

For the full year 2026, we currently expect a growing (previously broadly stable to slightly growing) total PMI cigarette and SFP shipment volume, with high single-digit SFP shipment growth, led by high single-digit SFP adjusted IMS growth, and a cigarette shipment volume decline at a similar level to the year-to-date trend (previously around 2% to 3%).

Previous wording

(1) Cost variance includes charges in 2026 and 2025 of $30 million and $243 million, respectively, related to restructuring charges. For more details, see Note 15. Restructuring Activities.

Current wording

(1) Cost variance includes charges in 2026 and 2025 of $34 million and $243 million, respectively, related to restructuring charges and $176 million related to the Germany excise tax classification litigation charge in 2025. For more details, see Note 15. Restructuring Activities and the "Executive Summary" section of this MD&A.

Previous wording

For the six months ended June 30, 2026, net revenues increased by 9.8%. Net revenues, excluding currency and acquisitions/divestitures, increased by 5.3%, mainly reflecting: a favorable pricing variance mainly driven by international combustibles; partly offset by unfavorable volume/mix, mainly driven by lower international combustibles and U.S. volumes, notwithstanding higher international smoke-free volumes.

Current wording

For the nine months ended September 30, 2026, net revenues increased by 8.2%. Net revenues, excluding currency and acquisitions/divestitures, increased by 5.9%, mainly reflecting: a favorable pricing variance mainly driven by international combustibles; and higher international smoke-free volumes; partly offset by unfavorable volume/mix, mainly driven by lower international combustibles and U.S. volumes in the first quarter.

Previous wording

Operating income increased by 16.1%. Operating income, excluding currency and acquisitions/divestitures, increased by 10.4%, mainly reflecting: the same factors as for net revenues and lower restructuring charges in 2026, partially offset by higher marketing, administration and research costs.

Current wording

Operating income increased by 15.4%. Operating income, excluding currency and acquisitions/divestitures, increased by 12.1%, mainly reflecting: the same factors as for gross profit, lower restructuring charges in 2026 and the 2025 Germany excise tax classification litigation charge of $176 million, partially offset by higher marketing, administration and research costs.

Previous wording

Interest expense, net, of $480 million decreased by $38 million or 7.3%, primarily due to higher interest income on investments.

Current wording

Interest expense, net, of $679 million decreased by $69 million or 9.2%, primarily due to higher interest income on investments.

Previous wording

Our effective tax rate increased by 1.0 percentage point to 20.5%. We estimate that our 2026 effective tax rate will be around 21.5%, excluding discrete tax events. For further details, see Note 10. Income Taxes.

Current wording

Our effective tax rate increased by 1.7 percentage points to 20.9%. We estimate that our 2026 effective tax rate will be around 21.5%, excluding discrete tax events. For further details, see Note 10. Income Taxes.

Previous wording

We recorded a non-cash impairment charge of $511 million related to our RBH equity investment in the condensed consolidated statement of earnings for the six months ended June 30, 2026. For further details, see Note 13. Related Parties - Equity Investments and Other.

Current wording

We recorded a non-cash impairment charge of $511 million related to our RBH equity investment in the condensed consolidated statement of earnings for the nine months ended September 30, 2026. For further details, see Note 13. Related Parties - Equity Investments and Other.

Previous wording

Equity investments and securities (income)/loss net was a loss of $244 million in 2026 compared to income of $(581) million in 2025. The variance was primarily due to the unfavorable fair value adjustments for our equity security investments in India and Sri Lanka. For further details, see Note 13. Related Parties - Equity Investments and Other.

Current wording

Equity investments and securities (income)/loss net was a loss of $330 million in 2026 compared to income of $(926) million in 2025. The variance was primarily due to the unfavorable fair value adjustments for our equity security investments in India and Sri Lanka. For further details, see Note 13. Related Parties - Equity Investments and Other.

Previous wording

Net earnings attributable to PMI of $5.3 billion decreased by $0.5 billion or 8.3%. This decrease was primarily due to the unfavorable fair value adjustments for our equity security investments, the non-cash impairment charge related to our RBH equity investment and a higher effective tax rate, partly offset by higher operating income and lower interest expense, net. Basic and diluted EPS of $3.36 both decreased by 8.4%. Excluding a favorable currency impact of $0.22, diluted EPS decreased by 14.4%.

Current wording

Net earnings attributable to PMI of $8.6 billion decreased by $0.6 billion or 6.9%. This decrease was primarily due to the unfavorable fair value adjustments for our equity security investments, the non-cash impairment charge related to our RBH equity investment and a higher effective tax rate, partly offset by higher operating income and lower interest expense, net. Basic and diluted EPS of $5.49 and $5.48 decreased by 6.9% and 7.0%, respectively. Excluding a favorable currency impact of $0.20, diluted EPS decreased by 10.4%.

Previous wording

During the quarter, estimated industry volume (excluding China and the U.S.) for cigarettes and HTUs increased by 0.8%.

Current wording

During the quarter, estimated industry volume (excluding China and the U.S.) for cigarettes and HTUs was broadly stable, decreasing by 0.1%.

Previous wording

Our shipment volume, including cigarettes and smoke-free products (in equivalent units), increased by 2.5% driven by a 7.5% increase in smoke-free mainly due to IQOS and complemented by a resilient combustible segment, notably in markets where SFPs are banned or have a limited market presence.

Current wording

Our shipment volume, including cigarettes and smoke-free products (in equivalent units), increased by 0.6% driven by a 2.7% increase in smoke-free products, with shipment growth across all categories supported by high single-digit growth in adjusted SFP in-market sales, which is the closest proxy to consumer offtake. This was complemented by the continuing resilience of the combustible segment, notably in markets where SFPs are banned or have a limited market presence.

Showing the first 40 of 116 pairs. Open the source sections for the rest.

Rearranged current paragraphs (1)

Current report — wording carried from elsewhere

European Commission launched a stakeholder consultation for the revision of TPD in May 2026 and is expected to issue its potential legislative proposal by the end of 2026.
Rearranged previous paragraphs (10)

Previous report — wording carried elsewhere

Restructuring charges – During the second quarter of 2025, we recorded pre-tax restructuring charges of $243 million (representing $200 million net of income tax and a diluted EPS charge of $0.13 per share), related to the end of combustible tobacco production in two of our factories in Germany. For further details, see Note 15. Restructuring Activities.

Previous report — wording carried elsewhere

Impairment of goodwill –During the second quarter of 2025, after the completion of our annual review of goodwill, it was determined that the estimated fair value of a business, which was a separate reporting unit in 2025, related to the consumer accessories products acquired as part of the Swedish Match acquisition in 2022 was lower than its carrying value. Consequently, PMI recorded a goodwill impairment charge of $41 million (representing a $0.03 per share decrease in diluted EPS). For further details, see Note 5. Goodwill and Other Intangible Assets, net.

Previous report — wording carried elsewhere

Impairment related to RBH equity investment –In May 2026, pursuant to its obligation under its court-approved plan of compromise and arrangement (the "Plan"), RBH provided an annual business plan to its Plan Administrator containing updated five-year financial projections reflecting current industry dynamics. As a result, PMI determined that the estimated fair value of its investment in RBH was lower than its carrying value and recorded a non-cash impairment charge of $511 million (representing $0.33 per share decrease in diluted EPS) in the second quarter of 2026. For further details, see Note 13. Related Parties - Equity Investments and Other.

Previous report — wording carried elsewhere

Egypt sales tax settlement adjustment –In the third quarter of 2024, following a ruling issued by the Higher Administrative Court in Egypt and subsequent evaluation of available remedies at that time, we concluded that an adverse outcome was probable and recorded a pre-tax charge in 2024 of $45 million (representing a diluted EPS charge of $0.03 per share) in relation to tax assessments for general sales tax deducted on imported cutfiller for the years 2014 to 2016. Pursuant to tax amnesty legislation enacted in Egypt in December 2024, PMI submitted review requests with the Dispute Resolution Committee, which issued settlement recommendations subject to court approval. In May 2026, court approval was obtained for the settlement covering the 2016 year, which then became effective. As a result, PMI recorded a favorable sales tax settlement adjustment during the second quarter of 2026 of $18 million net of income tax (representing an increase of $0.01 to diluted EPS).

Previous report — wording carried elsewhere

The 2025 tax items that decreased our 2025 diluted EPS by $0.03 per share in the table above were due to the recognition of current tax expense related to the potential disallowance of deductions for certain intercompany transactions in Indonesia.

Previous report — wording carried elsewhere

•International Combustibles segment: Favorable pricing, partly offset by unfavorable mix;

Previous report — wording carried elsewhere

(1) Cost variance includes charges in 2026 and 2025 of $6 million and $243 million, respectively, related to restructuring charges. For more details, see Note 15. Restructuring Activities.

Previous report — wording carried elsewhere

We recorded an impairment charge of $511 million related to our RBH equity investment in the condensed consolidated statement of earnings for the three months ended June 30, 2026. For further details, see Note 13. Related Parties - Equity Investments and Other.

Previous report — wording carried elsewhere

We believe that such tax policies undermine public health by encouraging consumers to turn to illicit trade or negatively impact the transition of adult smokers to SFPs, and ultimately undercut government revenue objectives, disrupt the competitive environment, and encourage criminal activity. Other jurisdictions have imposed, or are seeking to impose, levies or other taxes specifically on tobacco companies, such as taxes on revenues and/or profits.

Previous report — wording carried elsewhere

Some members of the public health community are calling for further standardization of tobacco products by requiring, for example, that cigarettes have a certain minimum diameter, which would result in a ban on slim cigarettes, or requiring the use of standardized filter and cigarette paper designs. In the Netherlands, an anti-smoking organization has brought a lawsuit to force the government to require a different test method for measuring cigarette emissions than what is currently required under